Compare Summit Therapeutics Inc (SMMT) vs Sprott Uranium Miners ETF (URNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs Sprott Uranium Miners ETF — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Sprott Uranium Miners ETF trades at $50.32. Which is the better fit depends on your goals.
| SMMT | URNM | |
|---|---|---|
Market Cap | $10.48B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $29.32 | $83.99 |
52-Week Low | $13.05 | $44.14 |
Enterprise Value | $9.90B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About Sprott Uranium Miners ETF
URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →
